Anti-CD19, Dual Co-stimulatory (4-1BB, CD3Î¶) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)